IndiGo Stock: 21 Analysts Say Buy, ऑर्टन Cautions on Regulatory Risk

• IndiGo shares fell over 16.3% in a month due to mass flight cancellations in early December, leading to regulatory scrutiny.
• Strategist Orton advises against buying on dips until regulatory risks are clear, despite 21 out of 26 analysts recommending 'Buy'.
• The Competition Commission of India (CCI) is investigating potential rule violations, citing the airline's dominant market share.
• Estimated compensation for affected passengers is ₹500 crore, contributing to a ~$5 billion market cap reduction.
• Earnings per share (EPS) estimates for FY26 and FY27 have been significantly cut by 30% and 14% respectively.

Why It Matters: IndiGo's regulatory risks after cancellations impact investor confidence.